Vagus Nerve Stimulation Treatment for Asthmatic Bronchoconstriction

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 6R43HL135918-02
Agency Tracking Number: R43HL135918
Amount: $149,187.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NHLBI
Solicitation Number: PA15-269
Timeline
Solicitation Year: 2015
Award Year: 2017
Award Start Date (Proposal Award Date): 2017-02-01
Award End Date (Contract End Date): 2018-01-31
Small Business Information
1708 JAGGIE FOX WAY, STE 120, Lexington, KY, 40511-1162
DUNS: 079829394
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 MARK BATES
 (844) 919-9990
 mark@pulsusmed.com
Business Contact
 WILLIAM ROSELLINI
Phone: (972) 883-2111
Email: will@roselliniscientific.com
Research Institution
N/A
Abstract
Project Summary The Specific Aim of this proposal is to test the feasibility of using vagus nerve stimulation VNS for treating asthma related airway constriction that is refractory to current treatments There are approximately million people with asthma in the US About percent of these asthma sufferers experience early and late phase severe asthmatic bronchoconstriction that is refractory to current medication These patients account for more than half of health related asthma costs and the majority of its mortality This patient population accounts for emergency department visits per day hospitalizations per day and more than deaths annually There is currently no treatment for people who suffer from uncontrolled asthma Other percutaneous devices have proven effective for blocking the early phase of asthma attacks that are refractory to current therapy in an ED setting but there is currently no effective VNS device for outside of the ED setting In addition the efficacy of their device for blocking the later phase of the asthma response is unknown The late phase occurs in of individuals and may account for extended stand and returns to the ED Our goal is to provide patients with VNS for on demand treatment of both the early and late asthma responses in order to drastically improve quality of life prevent death and to obviate the need for visiting the ED However before evaluating our method in humans we must first determine if VNS is effective for halting both the early and the late phase of asthma In this Phase I study we will achieve our Specific Aim by evaluating the efficacy of VNS for blocking both early and late asthma responses in an ovalbumin OVA sensitized guinea pig model of asthma Guinea pigs are anesthetized with urethane g kg i p Heart rate and blood pressure are measured via a carotid artery cannula Both jugular veins are also cannulated for administration of drugs The left vagus nerve will be isolated and immersed in a pool of mineral oil and bipolar cuff electrode will be placed around the left cervical vagus Animalandapos s body temperature will be maintained at C using a heating blanket Animals are paralyzed with succinylcholine ml kg min i v and ventilated tidal volume ml g body weight at breaths per minute via a tracheal cannula using a constant volume pump Harvard Apparatus Co South Natick MA Bronchoconstriction measured as an increase in pulmonary inflation pressure Ppi via a pressure transducer on a sidearm of the tracheal cannula will be measured at stated time intervals after ovalbumin inhalation Test of Feasibility We must observe mean reduction of max respiratory system resistance when OVA is combined with VNS in comparison to sham VNS This value was chosen because it is both directly related to previously demonstrated pulmonary pressure change in guinea pigs and predictive of later clinically meaningful responses in humans Project Narrative This is a proposal to develop an on demand treatment for both immediate and long lasting symptoms of asthma using vagus nerve stimulation There are million Americans with asthma and approximately do not respond to current methods of treatment The proposed therapy seeks to mitigate debilitating symptoms and restore quality of life to patients suffering from uncontrolled asthma

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government